Troxerutin Sodium Chloride Injection

Troxerutin can inhibit platelet aggregation and prevent thrombosis. It can also counteract vascular manipulation caused by 5-hydroxytryptamine and bradykinin, increase capillary resistance, and reduce edema caused by increased vascular permeability in the eyes.

The main ingredient of this product is troxerutin, chemical name: 7,3',4'-trihydroxyethyl rutin. Molecular formula: C33H42O19 Molecular weight: 742.69

This product is a light yellow to yellow or light yellowish green to yellowish green clear liquid.

Used for ischemic cerebrovascular disease (such as cerebral thrombosis, cerebral embolism), central retinitis, arterial infection, coronary heart disease, thrombophlebitis, varicose veins, chronic venous insufficiency, etc.

Intravenous drip. 0.21g-0.48g (in terms of troxerutin) once a day, 20 days as a course of treatment, or follow the doctor's advice.

Occasionally there may be allergic reactions, gastrointestinal disorders, etc.

It is contraindicated for those who are allergic to this product.

Precautions for children: There is a lack of research and literature on the use of this product in children, and it is not recommended for children. Precautions for pregnancy and lactation: Not clear. Precautions for the elderly: There is a lack of research data on the use of this product in elderly patients.

Not yet clear

Keep away from light, sealed and stored in a dry place.

100ml: Troxerutin 0.4g and sodium chloride 0.9g

Year 2

Cisen Pharmaceutical Co., Ltd.

• Founded in:

  1998-11-06

• Address:

  Tongji Science and Technology Industrial Park, Jining High-tech Zone

• Tax NO.:

  91370800706117999P

• Registered Funds:

  452,754,129 yuan

• Website:

  Log in to view

• Email:

  Log in to view